3American Diabetes Association. Standards of medical care in dia-betes-2010[J]. Diabetes care,2010,33 Suppl 1:11-61.
4Song SY, Han YD,Park YM,et al. Bioelectroeatalytic de- tection of glycated hemoglobin(HbAlc)based on the com- petitive binding of target and signaling glycoproteins to a boronate-modified surface[J]. Biosens Bioelectron, 2012, 35(1) :355-362.
5Chuang YC, Lan KC, Hsieh KM, et al. Detection of gly- cated hemoglobin( HbA (lc)) based on impedance meas- urement with parallel electrodes integrated into a mi- crofluidic device[J]. Sens Actuators B Chem, 2012,171 (20) : 1222-1230.
6Risk factors associated with high glycated hemoglobin levels, (≥5. 7%)in Korean adults with normal fasting glucose[J].Journal of Endocrinological Investigation, 2012,35 (8) : 730-734.
7American Diabetes Association. Standards of medical care in diabe- tesd 2012 [ J ]. Diabetes Care, 2012, 35 (Suppl 1 ) : S11 - S63.
8Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent - onset diabe- tes in the Diabetes Prevention Program [ J ]. Diabet Med, 2007, 24 (2) : 137 -144.
9HERMAN W H. Diabetes epidemiology: guiding clinical and pub- lic health practice: the Kelly West Award Lecture, 2006[J]. Dia- betes Care, 2007, 30(7): 1912- 1919.
10SUMNER C J, SHETH S, GRIFFIN J W, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance [ J ]. Neuro- logy, 2003, 60(1): 108-111.
